Your browser doesn't support javascript.
loading
Current and emerging avenues for Alzheimer's disease drug targets.
Loera-Valencia, R; Cedazo-Minguez, A; Kenigsberg, P A; Page, G; Duarte, A I; Giusti, P; Zusso, M; Robert, P; Frisoni, G B; Cattaneo, A; Zille, M; Boltze, J; Cartier, N; Buee, L; Johansson, G; Winblad, B.
Affiliation
  • Loera-Valencia R; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
  • Cedazo-Minguez A; Division of Neurogeriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
  • Kenigsberg PA; Fondation Médéric Alzheimer, Paris, France.
  • Page G; Neurovascular Unit and Cognitive impairments - EA3808, University of Poitiers, Poitiers, France.
  • Duarte AI; CNC- Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
  • Giusti P; Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Coimbra, Portugal.
  • Zusso M; Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Padova, Italy.
  • Robert P; Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Padova, Italy.
  • Frisoni GB; CoBTeK - lab, CHU Nice University Côte d'Azur, Nice, France.
  • Cattaneo A; University Hospitals and University of Geneva, Geneva, Switzerland.
  • Zille M; University Hospitals and University of Geneva, Geneva, Switzerland.
  • Boltze J; Institute of Experimental and Clinical Pharmacology and Toxicology, Lübeck, Germany.
  • Cartier N; School of Life Sciences, The University of Warwick, Coventry, UK.
  • Buee L; Preclinical research platform, INSERM U1169/MIRCen Commissariat à l'énergie atomique, Fontenay aux Roses, France.
  • Johansson G; Université Paris-Sud, Orsay, France.
  • Winblad B; Alzheimer & Tauopathies, LabEx DISTALZ, CHU-Lille, Inserm, Univ. Lille, Lille, France.
J Intern Med ; 286(4): 398-437, 2019 10.
Article de En | MEDLINE | ID: mdl-31286586

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thérapie moléculaire ciblée / Maladie d'Alzheimer Limites: Humans Langue: En Journal: J Intern Med Sujet du journal: MEDICINA INTERNA Année: 2019 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thérapie moléculaire ciblée / Maladie d'Alzheimer Limites: Humans Langue: En Journal: J Intern Med Sujet du journal: MEDICINA INTERNA Année: 2019 Type de document: Article Pays d'affiliation: Suède Pays de publication: Royaume-Uni